Lilly: New phase 3b data for Taltz and Zepbound together vs Taltz alone
TradeXchange reports Lilly’s phase 3b results on Taltz and Zepbound together, showing broader biomarker changes versus Taltz alone, in adults with psoriasis and obesity.
TradeXchange reports Lilly’s phase 3b results on Taltz and Zepbound together, showing broader biomarker changes versus Taltz alone, in adults with psoriasis and obesity.